|
Volumn 1, Issue 1, 2001, Pages 13-20
|
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity
|
Author keywords
Opioids; Adenylyl cyclase; Mouse thymoma; Receptor down regulation
|
Indexed keywords
3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE;
3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE;
ADENYLATE CYCLASE;
KAPPA OPIATE RECEPTOR;
OPIATE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBODY PRODUCTION;
ARTICLE;
BINDING SITE;
CONTROLLED STUDY;
CYTOTOXICITY;
DESENSITIZATION;
ENZYME ACTIVITY;
IMMUNE RESPONSE;
MACROPHAGE ACTIVATION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR DOWN REGULATION;
RECEPTOR GENE;
TARGET CELL;
THYMOMA;
3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER;
ADENYLATE CYCLASE;
ANIMALS;
BENZENEACETAMIDES;
DOWN-REGULATION;
ENZYME INHIBITORS;
KINETICS;
MICE;
PYRROLIDINES;
RECEPTORS, OPIOID, KAPPA;
THYMOMA;
THYMUS NEOPLASMS;
TUMOR CELLS, CULTURED;
|
EID: 0035120470
PISSN: 15675769
EISSN: None
Source Type: Journal
DOI: 10.1016/S1567-5769(00)00011-4 Document Type: Article |
Times cited : (4)
|
References (36)
|